Available Reports
Reports are grouped into functional categories, as listed below:
Interventions
Reports describing interventions are described in the table below:
Report |
Choose this report for... |
Generating an exposure summary and plot for all subjects in a study of an investigational product, by dose and exposure time for the safety population, by treatment |
|
|
Comparing Distributions of interventions and demographic variables across treatment arms |
Screening all interventions and calculates and generates forest plots of risk differences, relative risks or odds ratios |
Findings
Reports examining patient findings are described in the table below:.
Report |
Choose this report for... |
Displaying Box Plots by treatment group representing the change from baseline in measurements for each test for a specified findings domain across various time windows or points in a study |
|
Comparing Distributions of findings and demographic variables across treatment arms |
|
Findings Mean Change from Baseline Tables | Listing the number (and percentage) of patients in each treatment arm at each visit for each specified test and then calculating the mean change from baseline for all patients in each group. |
Displaying Shift Plots to compare test measurements for a specified findings domain at baseline versus on-therapy values, and performing a matched pairs analysis on average score during baseline and a summary score during the trial |
|
Findings Shift Tables | Collecting all of the specified findings test results and constructing a table listing the number (and percentage) of subjects in each treatment arm that are considered high, normal, or low for each test, grouped by visit. |
Visualizing findings measurements across the timeline of a study |
|
Creating waterfall plots to show the distribution of changes in test measurements for a given Findings domain across subjects |
|
Visualizing peak values for lab measurements pertaining to Hy’s Law for detecting potential liver toxicity for all subjects across treatment arms |
Oncology1
Reports are described in the table below:
Report |
Choose this report for... |
This process creates a disease response swimmer plot and tables around either the best or last recorded response rates and calculated objective response rate for solid tumor oncology clinical trials. The results of these assessments are summarized based on selecting either the Best response per subject, based on preferred order: CR, PR, SD, PD for controlled terms, respectively, or Last recorded response. The objective response rate (the sum and percentage of subjects who had CR + PR assessment result) is also calculated and listed in the summary table. |
|
Progression free survival is used to describe how long patients can go without the disease without getting worse. This process uses a modified survival plot and hazard ratio plot to compare the number and percentage of patients who have tumor progression or death, with patients who show no tumor progression or death at the cut-off date. |
Reports
Reports are described in the table below:
Report |
Choose this report for... |
Generating a document of study comments obtained from source data pertaining to each subject. |
|
DSUR/PSUR Report | Generating a report for updating regulatory agencies regarding the safety of a clinical trial design and execution for the purpose of securing permission for the continuance of the trial. |
Adverse Events
Reports examining patient study events are described in the table below:
Report |
Choose this report for... |
Comparing Distributions of adverse events and demographic variables across treatment arms |
|
Adverse Events Incidence Rates | Tabulating the number of occurrences of each event and calculating their incidence rates. |
Generating adverse event narratives for clinical study reports |
|
Screening all adverse eventsand calculates and generates forest plots of risk differences, relative risks or odds ratios |
|
Algorithmic FDA Medical Query Risk Report | This process uses FMQs with associated algorithms together with data from DMSEX to query AE, LB, and CM for subjects meeting the specified qualifications and the performs Cochran-Mantel-Haenszel (CMH) tests on all 2 x 2 tables constructed from event incidence and treatment arm. Output is a two-sided plot with a dot plot showing percent occurrence and forest plot showing risk measurement along with a table listing number (and percentage) of subjects exhibiting each FMQ by specific qualification. |
Medical Query Risk Report | Screens medical query terms by performing Cochran-Mantel-Haenszel (CMH) tests on all 2 x 2 tables constructed from event incidence and treatment arm. Output is a two-sided plot with a dot plot showing percent occurrence and forest plot showing risk measurement. |
Creating a tabular and graphical overview of treatment emergent adverse events for the safety population by actual treatment arm |
Data Quality
Reports examining patient findings are described in the table below:.
Report |
Choose this report for... |
Identifying tests from findings domains that have the same result for the entire study |
|
|
Assesses the use of terminal digits by study sites when reporting their clinical findings to identify those sites that might exhibit biases in rounding issues or other problems with how they report data. |
Identifying sets of records that have identical values on more than one occasion within a subject or between subjects within a study site |
|
Determines whether individuals are missing data for all test codes across all Findings domains, based on data available at each visit number and time point number. |
|
Calculating Mahalanobis distance based on available data to detect subject inliers and outliers in multivariate space, and generating results by site to see which sites are extreme. |
|
Identifies outliers and identifies sites with excessive outliers.
|
Other Events
Reports examining patient study events are described in the table below:
Report |
Choose this report for... |
Clinical Events Distribution | Capturing clinical events specially tracked as being of interest to the particular study and reported in the CE domain. |
Creating Kaplan-MeierSurvival Curves for time to study discontinuation and associated statistics, grouped by treatment arm |
|
Comparing Distributions of events from a domain and demographic variables across treatment arms Note: This report should be considered as two: DS Distribution and MH Distribution, depending on which domain is specified in the dialog. |
|
Screening all events from the specified domain and calculates and generates forest plots of risk differences, relative risks or odds ratios Note: This report should be considered as two: DS Risk Report and MH Risk Report, depending on which domain is specified in the dialog. |
|
Grouping clinical mortality results by treatment arm and generating Kaplan-MeierSurvival Curves with associated statistics |
Subject Level
Reports using data from across multiple domains are described in the table below:.
Report |
Choose this report for... |
Adding data for various domains to the ADSL table corresponding to incidence of variables in the AE, CM, LB, and MH domains and a summary statistic for LB, EG, and VS domain values |
|
Compares distributions of demographic variables across treatment arms via a one-way ANOVA or contingency analysis. |
|
Patient Profiles | Profiling subjects is a powerful way to view all of the data for one or more subjects, enabling you to view their entire history and determine potential causes for unexpected events or findings. |
Study Flow Diagram | Generates a flow diagram to summarize the overall clinical trial data flow. |
Generating a graphical display and tabulation of study visit attendance. |